NUCLEAR STRUCTURE AND METAZOAN ORIGINS OF REPLICATION
核结构和后生动物复制起源
基本信息
- 批准号:6019416
- 负责人:
- 金额:$ 20.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-01 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DNA replication is central to the life cycle of every living organism.
Although considerable progress has been made in our understanding of how
this process is regulated in simple organisms, regulatory mechanisms in
higher eukaryotes remain largely unknown. By introducing Chinese
hamster ovary (CHO) cell nuclei into Xenopus egg extracts, the applicant
has produced the first cell-free system that will initiate DNA
replication preferentially at a physiologically utilized origin of
replication downstream of the dihydrofolate reductase (DHFR) gene.
Recognition of this origin requires some component of the CHO nucleus
that is assembled at a discrete point during G1-phase (Origin Decision
Point, ODP), after replication licensing and prior to restriction point
control. After each mitosis, the cell must re-assemble a highly
organized and functionally compartmentalized nucleus. In particular,
replication takes place at fixed sites within the nucleus that consist
of multiple coordinately regulated replicons joined to large
(approximately 0.1 microns) multiprotein complexes. Our working
hypothesis predicts that ODP represents the joining of replication
origins to this multiprotein complex. To address this hypothesis, we
will pulse label CHO cells with BrdU within the first 10 minutes of S-
phase and chase these cells through to the following mitosis.
Synchronized populations of CHO cells, containing BrdU-tagged origin-
proximal sequences, will then be collected at various times during G1-
phase and analyzed by fluorescence microscopy for the time at which
these sequences 1) re-establish their early S-phase pattern of foci, 2)
become attached to a fixed nuclear substratum, 3) become functionally
recognizable as the sites at which to begin DNA synthesis when nuclei
from these cells are introduced into Xenopus egg extracts, and 4) first
co-localize with antibodies directed against essential replication
initiation factors. Parallel experiments will monitor the spatial
position and attachment to the matrix of specific origin-containing and
non-origin probes that decorate the DHFR replicon using Fluorescence In
Situ Hybridization to CHO cells synchronized in different stages of G1-
phase. Having established the sequence of these events, we will disrupt
the assembly of the nucleus through 1) the controlled overexpression of
dominant negative nuclear lamina proteins that have been shown to
interfere with the initiation of replication and 2) treatment of cells
with inhibitors of Topoisomerase II, one of which has been shown to
inhibit the selection of origins at the ODP. We will then determine
which steps in the assembly of functional replication origins are
interrupted by these disruptions in nuclear structure.
DNA复制是每个生物体生命周期的核心。
尽管我们在理解如何
这一过程在简单的生物体中受到调节,
高等真核生物仍然是未知的。 通过介绍中文
仓鼠卵巢(CHO)细胞核转化为非洲爪蟾卵提取物,申请人
产生了第一个无细胞系统,
复制优先在生理上利用的起点,
二氢叶酸还原酶(DHFR)基因的下游复制。
识别这种起源需要CHO细胞核的某些成分
在G1阶段(原产地决策)的离散点组装
点,ODP),在复制许可之后和限制点之前
控制 每次有丝分裂后,细胞必须重新组装一个高度
有组织的功能分区的核心。 特别是,
复制发生在细胞核内的固定位点,
多个协同调节的复制子连接到大的
(约0.1微米)多蛋白复合物。 我们的工作
假设预测ODP代表复制的加入
这个多蛋白复合物的起源。 为了解决这个问题,我们
将在S-10的前10分钟内用BrdU脉冲标记CHO细胞。
使这些细胞进行有丝分裂。
CHO细胞的同步群体,含有BrdU标记的来源-
然后将在G1期间的不同时间收集近端序列,
相,并通过荧光显微镜分析,
这些序列1)重新建立它们的早期S期病灶模式,2)
附着在固定的核基质上,3)在功能上变得
可识别为当细胞核分裂时开始DNA合成的位点
从这些细胞中引入爪蟾卵提取物,和4)首先
与针对基本复制的抗体共定位
启动因素 平行实验将监测空间
特定来源的基质的位置和附着,
使用荧光探针修饰DHFR复制子,
与在G1-G4的不同阶段同步化的CHO细胞的原位杂交
相位 在确定了这些事件的顺序之后,我们将破坏
细胞核的组装是通过1)
显性负核纤层蛋白已被证明,
干扰复制的起始和2)处理细胞
拓扑异构酶II抑制剂,其中一种已被证明
抑制ODP的起源选择。 然后我们将决定
在功能性复制起点的组装中,
被这些核结构的破坏所打断
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David M Gilbert其他文献
Intranuclear changes in cancer cells
- DOI:
10.1186/gb-2007-8-8-312 - 发表时间:
2007-01-01 - 期刊:
- 影响因子:9.400
- 作者:
David M Gilbert;Daniele Zink - 通讯作者:
Daniele Zink
Roles of Rif1 in regulation of DNA replication, transcription and DNA repair
Rif1 在 DNA 复制、转录和 DNA 修复调节中的作用
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Satoshi Yamazaki;Jiao Sima;Yumeka Matsushima;Kenji Moriyama;Naoko Yoshizawa;Sara Buonomo;David M Gilbert;Hisao Masai - 通讯作者:
Hisao Masai
David M Gilbert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David M Gilbert', 18)}}的其他基金
Oncogenic pathway-induced fragile sites: a new paradigm for understanding genome instability in cancer
致癌途径诱导的脆弱位点:了解癌症基因组不稳定性的新范例
- 批准号:
10589809 - 财政年份:2022
- 资助金额:
$ 20.16万 - 项目类别:
Mapping the 3D architecture of native human replisomes
绘制天然人类复制体的 3D 架构
- 批准号:
10461210 - 财政年份:2019
- 资助金额:
$ 20.16万 - 项目类别:
Mapping the 3D architecture of native human replisomes
绘制天然人类复制体的 3D 架构
- 批准号:
10400294 - 财政年份:2019
- 资助金额:
$ 20.16万 - 项目类别:
Replication domain organization during hESC differentiation
hESC 分化过程中的复制域组织
- 批准号:
8641824 - 财政年份:2014
- 资助金额:
$ 20.16万 - 项目类别:
Replication Profiling as a Diagnostic Tool in B-cell Acute Lymphoblastic Leukemia
复制分析作为 B 细胞急性淋巴细胞白血病的诊断工具
- 批准号:
8594233 - 财政年份:2012
- 资助金额:
$ 20.16万 - 项目类别:
Replication Profiling as a Diagnostic Tool in B-cell Acute Lymphoblastic Leukemia
复制分析作为 B 细胞急性淋巴细胞白血病的诊断工具
- 批准号:
8445645 - 财政年份:2012
- 资助金额:
$ 20.16万 - 项目类别:
Replication Domain Organization during hESC Differentiation
hESC 分化期间的复制域组织
- 批准号:
8382720 - 财政年份:2012
- 资助金额:
$ 20.16万 - 项目类别:
Genome Plasticity during ES Cell Differentiation to Neural Lineages
ES 细胞分化为神经谱系期间的基因组可塑性
- 批准号:
7910975 - 财政年份:2009
- 资助金额:
$ 20.16万 - 项目类别:
cis-Acting Elements Regulating Developmental Control of Replication Timing
调节复制时间发育控制的顺式作用元件
- 批准号:
8238959 - 财政年份:2007
- 资助金额:
$ 20.16万 - 项目类别:
相似海外基金
Understanding and exploiting DNA topoisomerases in cancer biology
了解和利用癌症生物学中的 DNA 拓扑异构酶
- 批准号:
10296437 - 财政年份:2021
- 资助金额:
$ 20.16万 - 项目类别:
Understanding and exploiting DNA topoisomerases in cancer biology
了解和利用癌症生物学中的 DNA 拓扑异构酶
- 批准号:
10473793 - 财政年份:2021
- 资助金额:
$ 20.16万 - 项目类别:
Structural and mechanistic analysis of type II DNA topoisomerases
II 型 DNA 拓扑异构酶的结构和机制分析
- 批准号:
2059935 - 财政年份:2018
- 资助金额:
$ 20.16万 - 项目类别:
Studentship
Conference: 2016 Gordon Research Seminar on DNA Topoisomerases to be held at Sunday River in Newry, ME on August 6-7, 2016
会议:2016 年戈登 DNA 拓扑异构酶研究研讨会将于 2016 年 8 月 6 日至 7 日在缅因州纽里的 Sunday River 举行
- 批准号:
1643077 - 财政年份:2016
- 资助金额:
$ 20.16万 - 项目类别:
Standard Grant
2014 DNA Topoisomerases in Biology and Medicine Gordon Research Conference
2014 DNA 拓扑异构酶在生物学和医学戈登研究会议
- 批准号:
8714782 - 财政年份:2014
- 资助金额:
$ 20.16万 - 项目类别:
Biochemical Analyses of Type II DNA Topoisomerases
II 型 DNA 拓扑异构酶的生化分析
- 批准号:
7909236 - 财政年份:2009
- 资助金额:
$ 20.16万 - 项目类别:
DNA Topoisomerases and DNA Topology in E. coli
大肠杆菌中的 DNA 拓扑异构酶和 DNA 拓扑
- 批准号:
0090880 - 财政年份:2001
- 资助金额:
$ 20.16万 - 项目类别:
Continuing Grant